Skip to content
← Lobby register
TB
Other

Terumo Blood and Cell Technologies

🇪🇺 BELGIUMRegistered 14/01 staff
Disclosed budget
€200,000 — €299,999
Meetings 12mo
0
Policy files
0
Accredited passes
1

Recent meetings

No recorded meetings with EU commissioners.

Mission & Goals

Terumo BCT, a global leader in blood component and cellular technologies, is the only company with the unique combination of apheresis collections, manual and automated whole blood processing, and pathogen reduction coupled with leading technologies in therapeutic apheresis and cell processing. We believe in the potential of blood to do even more for patients than it does today. This belief inspires our innovation and strengthens our collaboration with customers.

EU Legislative Interests

Medical Device Regulation REACH & chemical restrictions EU Green Deal SoHo Regulation Public Procurement Directive Biotech Act Non-legislative policies on rare diseases, health inequality, blood health etc.

Interests Represented

Promotes their own interests or the collective interests of their members

Member Of

MedTech Europe www.medtecheurope.org/ MedPharmPlast www.medpharmplasteurope.org/ Blood Transfusion Association (BTA) https://bloodtransfusionassociation.org/ Brussels Resilience Forum